BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3491837)

  • 21. Endothelial-derived von Willebrand factor accelerates fibrin clotting within engineered microvessels.
    Rayner SG; Scholl Z; Mandrycky CJ; Chen J; LaValley KN; Leary PJ; Altemeier WA; Liles WC; Chung DW; López JA; Fu H; Zheng Y
    J Thromb Haemost; 2022 Jul; 20(7):1627-1637. PubMed ID: 35343037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epinephrine induces von Willebrand factor release from cultured endothelial cells: involvement of cyclic AMP-dependent signalling in exocytosis.
    Vischer UM; Wollheim CB
    Thromb Haemost; 1997 Jun; 77(6):1182-8. PubMed ID: 9241755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue factor: A potent stimulator of Von Willebrand factor synthesis by human umbilical vein endothelial cells.
    Meiring M; Allers W; Le Roux E
    Int J Med Sci; 2016; 13(10):759-764. PubMed ID: 27766025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photosensitized release of von Willebrand factor from cultured human endothelial cells.
    Foster TH; Primavera MC; Marder VJ; Hilf R; Sporn LA
    Cancer Res; 1991 Jun; 51(12):3261-6. PubMed ID: 1828189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors.
    Kirchhofer D; Tschopp TB; Hadváry P; Baumgartner HR
    J Clin Invest; 1994 May; 93(5):2073-83. PubMed ID: 8182139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. von Willebrand factor and the endothelium.
    Wagner DD; Bonfanti R
    Mayo Clin Proc; 1991 Jun; 66(6):621-7. PubMed ID: 2046401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteoprotegerin (OPG) is localized to the Weibel-Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor.
    Zannettino AC; Holding CA; Diamond P; Atkins GJ; Kostakis P; Farrugia A; Gamble J; To LB; Findlay DM; Haynes DR
    J Cell Physiol; 2005 Aug; 204(2):714-23. PubMed ID: 15799029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Von Willebrand disease and Weibel-Palade bodies.
    Wang JW; Eikenboom J
    Hamostaseologie; 2010 Aug; 30(3):150-5. PubMed ID: 20680229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of von willebrand factor of human endothelial cells exposed to laminar flows: an in vitro study.
    Sun RJ; Muller S; Wang X; Zhuang FY; Stoltz JF
    Clin Hemorheol Microcirc; 2000; 23(1):1-11. PubMed ID: 11214708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells.
    Wagner DD; Olmsted JB; Marder VJ
    J Cell Biol; 1982 Oct; 95(1):355-60. PubMed ID: 6754744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of von Willebrand factor on clot structure and lysis.
    Marchi R; Rojas H
    Blood Coagul Fibrinolysis; 2015 Jul; 26(5):533-6. PubMed ID: 25811448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlative light microscopy and electron tomography to study Von Willebrand factor exocytosis from vascular endothelial cells.
    Mourik MJ; Faas FG; Valentijn KM; Valentijn JA; Eikenboom JC; Koster AJ
    Methods Cell Biol; 2014; 124():71-92. PubMed ID: 25287837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perturbation of cultured human vascular endothelial cells by phorbol ester or thrombin alters the cellular von Willebrand factor distribution.
    Reinders JH; Vervoorn RC; Verweij CL; van Mourik JA; de Groot PG
    J Cell Physiol; 1987 Oct; 133(1):79-87. PubMed ID: 3499441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial cell surface expression and binding of factor VIII/von Willebrand factor.
    Jones TR; Kao KJ; Pizzo SV; Bigner DD
    Am J Pathol; 1981 May; 103(2):304-8. PubMed ID: 6786103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of cysteine 584 impairs the storage and release, but not the synthesis of von Willebrand factor.
    Daidone V; Barbon G; Pontara E; Cattini GM; Gallinaro L; Zampese E; Pizzo P; Casonato A
    Thromb Haemost; 2014 Dec; 112(6):1159-66. PubMed ID: 25230768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. von Willebrand factor storage requires intact prosequence cleavage site.
    Journet AM; Saffaripour S; Cramer EM; Tenza D; Wagner DD
    Eur J Cell Biol; 1993 Feb; 60(1):31-41. PubMed ID: 8462598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inducible secretion of large, biologically potent von Willebrand factor multimers.
    Sporn LA; Marder VJ; Wagner DD
    Cell; 1986 Jul; 46(2):185-90. PubMed ID: 3087627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biogenesis and exocytosis of Weibel-Palade bodies.
    van Mourik JA; Romani de Wit T; Voorberg J
    Histochem Cell Biol; 2002 Feb; 117(2):113-22. PubMed ID: 11935287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth factors for human fibroblasts in the solute remaining after clot formation.
    Gray AJ; Reeves JT; Harrison NK; Winlove P; Laurent GJ
    J Cell Sci; 1990 Jun; 96 ( Pt 2)():271-4. PubMed ID: 2211868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.